SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 386.47-0.2%4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Joseph Silent
voop
To: Dr. Voodoo who wrote (156501)4/14/2020 10:22:04 AM
From: carranza22 Recommendations  Read Replies (3) of 218185
 
Nice.

In order to attack T cells, the virus must first replicate. In order to replicate it must enter other cells. In order to enter other cells, it must attach itself.

Change the pH of the cells the virus is trying to enter, and entry won’t happen. The virus dies. T cells survive to fight another day.

There are several ways to change the pH of target cells: quinine (natural and artificial); ammonium chloride; camostat metylase; and a dangerous anti-anxiety drug whose name I don’t recall. There may be more.

The 2005 paper that got me interested in chloroquine discussed the pH issue. It was authored by a Canadian and USA team. The USA team was employed by the CDC.

I now see that the pH issue as a means of fighting virus attachment has been discussed in the scientific literature since at least 1967. That’s not a typo.

Anti-virals are hard, take much research, and produce expensive (and profitable) drugs. On the other hand, pH changing drugs are cheap, off-patent, well-known and, while not perfect, they will do in the face of a dangerous pandemic while a vaccine is being developed. Thus, that would be my strategy: go in feet first on the pH changers while development of anti-virals and a vaccine takes place.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News